Table 5.
Significant Metabolic Signatures | Population or Phenotype | Sample | AUC Values | Ref. | |
---|---|---|---|---|---|
Carbohydrates | |||||
Glucose | A/H | serum, ↓ | [177] | ||
O > L/ON | EBC | [193] | |||
Monosaccharide | N > E > H | serum | [180] | ||
Maltose | A/H | plasma, ↑ | [182] | ||
Maltotriose | A/H | plasma, ↑ | [182] | ||
D-Glyceric acid | O < L | serum | [184] | ||
D-Glucoheptose 1 | O > L | sputum | [184] | ||
Amino acid Metabolism | |||||
Alanine | A/H | EBC, ↑ | [191] | ||
N-Methyl-DL-alanine | O > L | serum | [184] | ||
Arginine | A/H | serum, ↓ | [177] | ||
A/H | EBC, ↑ | [191] | |||
Glutamine | A/H | serum, ↑ | [177] | ||
L-glutamic acid | O > L | sputum | [184] | ||
β-glutamic acid 1 | O > L | sputum | [184] | ||
Histidine | A/H | serum, ↓ | [177] | ||
Isoleucine | O < L | PBMCs | [184] | ||
A/H | EBC, ↑ | [191] | |||
Methionine | A/H | serum, ↑ | [177] | ||
Phenylalanine | A/H | EBC, ↑ | [191] | ||
Proline | A/H | EBC, ↑ | [191] | ||
Tyrosine | A/H | EBC, ↓ | [191] | ||
O < L/ON | EBC | [193] | |||
Valine | O > L | serum | [184] | ||
A/H | EBC, ↓ | [191] | |||
Taurine | A/H | plasma, ↑ | [182] | ||
Gly-pro | O > L | sputum | [184] | ||
5-Aminobaleric acid | A/H | serum, ↑ | 0.948 | [178] | |
N,N-Dimethylglycine | A/H | EBC, ↑ | [192] | ||
3-Hydroxynorvaline 2 | O < L | PBMCs | [184] | ||
Lipid metabolism | |||||
Choline | A/H | serum, ↓ | [177] | ||
Glycerolipids | Phosphatidylcholine (20:4/16:1) | H > N > E | serum | [180] | |
Phosphatidylcholine (18:1/2:0) | N > E > H | serum | [180] | ||
Phosphatidylcholine (16:0/18:1) | E > N > H | serum | [180] | ||
Acyl-alkyl-phosphatidylcholine (C42:4) | A/H | serum, ↑ | [176] | ||
Acyl-alkyl-phosphatidylcholine (C42:5) | A/H | serum, ↑ | [176] | ||
Acyl-alkyl-phosphatidylcholine (C44:5) | A/H | serum, ↑ | [176] | ||
Acyl-alkyl-phosphatidylcholine (C44:6) | A/H | serum, ↑ | [176] | ||
Phosphatidylethanolamine | A/H | plasma, ↑ | [182] | ||
Phosphatidylethanolamine (38:1) | A/H | plasma, ↑ | 0.746 | [183] | |
Phosphatidylethanolamine (18:1p/22:6) | A/H | plasma, ↑ | 0.731 | [183] | |
Phosphatidylethanolamine (20:0/18:1) | A/H | plasma, ↑ | 0.710 | [183] | |
Phosphatidylethanolamine (18:3/14:0) | E > N > H | serum | [180] | ||
Phosphatidylglycerol (44:0) | A/H | plasma, ↓ | 0.675 | [183] | |
Glycerophosphorylcholine | A/H | plasma, ↑ | [182] | ||
H > N > E | serum | [180] | |||
Β-glycerophosphorate | O > L | serum | [184] | ||
Lysophosphatidylcholine (18:1) | E > N > H | serum | [180] | ||
Lysophosphatidylcholine (22:4) | A/H | plasma, ↓ | 0.689 | [183] | |
Phosphatidylinositol | A/H | plasma, ↓ | 0.723 | [183] | |
Triglyceride (17:0/18:0/18:0) | A/H | plasma, ↑ | 0.714 | [183] | |
Triglyceride (16:0/16:0/18:1) | A/H | plasma, ↑ | 0.661 | [183] | |
O-phosphocholine | A/H | serum, ↓ | [177] | ||
Fatty acids | Saturated fatty acid | A/H | EBC, ↓ | [191] | |
O < L/ON | EBC | [193] | |||
Arachidonic acid | N > E > H | serum | [180] | ||
Arachidonate (20:4n6) | A/H | plasma, ↑ | [182] | ||
Isobutyrate | A/H | EBC, ↑ | [191] | ||
Linolenic acid | O < L | PBMCs | [184] | ||
N-palmitoyltaurine | SA | serum, ↓ | [179] | ||
Oleamide | A/H | plasma, ↓ | [182] | ||
n-valerate | O > L | EBC | [193] | ||
O < ON | EBC | [193] | |||
Isovalerate | O > L | EBC | [193] | ||
Sphingolipids | Sphingosine | A/H | plasma, ↑ | [182] | |
Sphingosine-1-phosphate | SA | serum, ↑ | [179] | ||
Sphingomyelin (d18:1/18:1) | A/H | plasma, ↑ | 0.731 | [183] | |
Phytosphingosine | H > N > E | serum | [180] | ||
Phytosphingosine 2 | O > L | sputum | [184] | ||
Sphinganine | H > N > E | serum | [180] | ||
Ceramide (d16:0/27:2) | A/H | plasma, ↓ | 0.690 | [183] | |
Eicosanoids | Leukotriene E4 | SA, T2 | urine, ↑ | [187] | |
Tetranor prostaglandin D metabolites | SA, T2 | urine, ↑ | [187] | ||
2,3-dinor-11β-PGF2α | SA, T2 | urine, ↑ | [187] | ||
8-iso-PGF2α | SA | urine, ↑ | [187] | ||
2,3-dinor-8-iso-PGF2α | SA | urine, ↑ | [187] | ||
Sterol/Steroids | Androsterone sulfate | A/H | plasma, ↓ | [182] | |
Epiandrosterone sulfate | A/H | plasma, ↓ | [182] | ||
Dehydroepiandrosterone sulfate | SA | serum, ↓ | [179] | ||
Glycodeoxycholate | A/H | plasma, ↑ | [182] | ||
Taurocholate | A/H | plasma, ↑ | [182] | ||
Lathosterol | A/H | plasma, ↑ | [182] | ||
Retinol | H > N > E | serum | [180] | ||
Carboxylic acid | |||||
Acetate | A/H | serum, ↓ | [180] | ||
A/H | EBC, ↑/↓ | [180] | |||
O < L/ON | EBC | [180] | |||
Butyrate | A/H | EBC, ↑ | [180] | ||
O > ON | EBC | [180] | |||
Formate | A/H | serum, ↓ | [180] | ||
A/H | EBC, ↓ | [180] | |||
O < L/ON | EBC | [180] | |||
Propionate | A/H’ | EBC, ↑ | [180] | ||
O < L/ON | EBC | [180] | |||
TCA cycle | |||||
Succinic acid | A/H | serum, ↑ | 0.976 | [191] | |
A/H | EBC, ↑/↓ | [191] | |||
Nucleoside/Nucleotide | |||||
Inosine | A/H | serum, ↑ | 0.962 | [178] | |
Adenosine | A/H | EBC, ↓ | [191] | ||
Other organic compounds | |||||
Acetoin | O > L/ON | EBC | [193] | ||
Alcohol | Ethanol | A/H | EBC, ↑ | [191] | |
O < L/ON | EBC | [193] | |||
Ethylene glycol | O < ON | EBC | [193] | ||
Isopropanol | A/H | EBC, ↑ | [192] | ||
Methanol | A/H | serum, ↓ | [177] | ||
A/H | EBC, ↑ | [177] | |||
A/H | EBC, ↑ | [191] | |||
O < L/ON | EBC | [191] | |||
1,2-propanediol | O > L | EBC | [193] | ||
Amines | Trimethylamine | A/H | EBC, ↓ | [191] | |
Ascorbate | A/H | serum, ↑ | 0.917 | [178] | |
3-aminopropionitrile 1 | O > L | sputum | [184] | ||
Benzene | 3,4-Dihydroxybenzoic acid | A/H | serum, ↑ | 0.965 | [178] |
Hippurate | A/H | EBC, ↓ | [191] | ||
3-Hydroxybutyric acid | O > L | sputum | [184] | ||
Ketones bodies | Acetone | A/H | serum, ↓ | [177] | |
O < L | EBC | [193] | |||
2-Ketovaleric acid | A/H | serum, ↑ | 0.874 | [178] | |
Lactate | O < L | EBC | [193] | ||
Urocanic acid | A/H | EBC, ↓ | [191] | ||
Dehydroascorbic acid | A/H | serum, ↑ | 0.896 | [178] | |
Urea | A/H | plasma, ↓ | [182] | ||
A/H | EBC, ↑ | [192] | |||
Uric acid | O > L | serum, ↑ | [184] | ||
Xanthine | O > L | sputum | [184] | ||
Inorganic compounds | |||||
Ammonia | A/H | EBC, ↓ | [192] | ||
Pyrophosphate-3 | O > L | sputum | [184] |
A, asthmatics; H, healthy controls; O, obese asthmatics; L, lean asthmatics; ON, obese non-asthmatics; E, eosinophilic asthma; N, non-eosinophilic asthma; SA, severe asthma; T2, type 2 inflammation marker; ↓, lower in asthma; ↑, higher in asthma.